Aaron B. Lerner
Lectureship Series

Dr. Karen Ashe
University of Minnesota, Twin Cities
Department of Neurology

Human relevance of a common Alzheimer mouse model.

Tuesday, November 17, 2009
12:20 pm in Mayo Auditorium, Minneapolis Campus

Background - Aaron B. Lerner
Aaron Lerner received his MD, Ph.D. degree from the University and went on to an outstanding research and teaching career at the Yale School of Medicine specializing in the metabolic basis of inherited disease, specifically vitilego.

Lerner Lectures
The focus on this seminar series is on the linkage between human disease and biochemical mechanisms.

Year	Speaker/Affiliation	Title
2001-2	Dr. Vincent J. Hearing National Cancer Institute, Bethesda, MD	Mechanisms of Hypopigmentation in Human Hypopigmentary Diseases.
2002-3	Dr. Paul Watkins Johns Hopkins School of Medicine, Baltimore, MD	X-linked Adrenoleukodystrophy: Is there a problem with 'Bubblegum" in the Brain?
2003-4	Dr. Jean Schaffer Washington Univeristy School of Medicine, St. Louis, MO	Lipotoxicity: when tissues overeat.
2004-5	Dr. Arnold W. Strauss, MD Vanderbilt University, Nashville, TN	Cancelled
2005-6	Dr. Michael Jensen Mayo Clinic, Rochester, MN	Role of Adipose Tissue Fatty Acid Release in Human Metabolic Disease.
2006-7	Dr. Michael Jensen Mayo Clinic, Rochester, MN	Role of Adipose Tissue Fatty Acid Release in Human Metabolic Disease.
2007-8	Dr. Harry "Chip" Davis, Schering-Plough Research Institute, Kenilworth, NJ	Zetia (Ezetimibe): Inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to Reduce Intestinal Cholesterol Absorption and Treat Hyperlipidemia.
2008-9	Dr. Berhnhard Hering, Dept. Surgery, University of Minnesota	Transformative Therapeutics to Cure Type 1 Diabetes.